Soliton to Present Poster on Pivotal Cellulite Data at Virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting

HOUSTON, Oct. 5, 2020 /PRNewswire/ — Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary aesthetic platform technology, today announced the Company has been accepted to present its pivotal cellulite data via an online poster during the Virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting, taking place October 9-11, 2020.

The poster presentation titled, “Improvement in the Appearance of Cellulite Depressions and Skin Laxity Resulting from a Single Treatment with Acoustic Subcision: Findings from a Multi-Center Pivotal Trial”, will be available to registered attendees beginning October 9, 2020 at 8:00 a.m. ET.

————————
Join our more than 200K subscribers here to follow the Company: https://soly-investors.com
————————

About Soliton, Inc.

Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer Center.

Read More

Soliton to Present Poster on Pivotal Cellulite Data at Virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting | News

HOUSTON, Oct. 5, 2020 /PRNewswire/ — Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary aesthetic platform technology, today announced the Company has been accepted to present its pivotal cellulite data via an online poster during the Virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting, taking place October 9-11, 2020.

The poster presentation titled, “Improvement in the Appearance of Cellulite Depressions and Skin Laxity Resulting from a Single Treatment with Acoustic Subcision: Findings from a Multi-Center Pivotal Trial”, will be available to registered attendees beginning October 9, 2020 at 8:00 a.m. ET.

————————
Join our more than 200K subscribers here to follow the Company: https://soly-investors.com
————————

About Soliton, Inc.

Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer Center. The

Read More

Soliton to Present Poster on Pivotal Cellulite Data at Virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting | Nachricht

HOUSTON, Oct. 5, 2020 /PRNewswire/ — Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary aesthetic platform technology, today announced the Company has been accepted to present its pivotal cellulite data via an online poster during the Virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting, taking place October 9-11, 2020.

The poster presentation titled, “Improvement in the Appearance of Cellulite Depressions and Skin Laxity Resulting from a Single Treatment with Acoustic Subcision: Findings from a Multi-Center Pivotal Trial”, will be available to registered attendees beginning October 9, 2020 at 8:00 a.m. ET.

————————
Join our more than 200K subscribers here to follow the Company: https://soly-investors.com
————————

About Soliton, Inc.

Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer Center. The

Read More